Skip to main content

Table 1 The demographic and clinical characteristics of the study patients

From: The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study

Variable

Age(year)

All cases

55.2 ± 11.9(28–75)

Gender(n, %)

Male

100, 65.4

Female

53, 34.6

Etiology of cirrhosis(n, %)

 

hepatitis B

100, 65.4

hepatitis C

11, 7.2

alcoholic liver disease

19, 12.4

nonalcoholic fatty liver disease

10, 6.5

autoimmune liver disease

10, 6.5

unknown causes

3, 2.0

Cirrhosis with liver cancer(n,%)

Yes

19, 12.4

NO

134, 87.6

Child-Pugh class (n,%)

A

96, 62.7

B

43, 28.1

C

14, 9.2

Endoscopic treatment (n,%)

EVL

54, 35.3

EIS

80, 52.3

EVL + EIS

19, 12.4

Recurrence of EV (n,%)

within 1 year

89, 58.2

1–3 years

54, 35.3

Mean time of recurrence (months)

From eradication to recurrence

13.4